MEDIKUNION

What MEDIKUNION does

MEDIKUNION is a Serbian pharmaceutical company founded in 1994 and headquartered in Belgrade, operating as a 100% privately held entity (MEDIKUNION DOO BEOGRAD). The company specializes in the import of unregistered medicines for patients and healthcare institutions in Serbia, a niche regulatory category that addresses supply gaps for medications not approved in the domestic market. MEDIKUNION also distributes registered pharmaceutical products and offers drug registration, marketing, and pharmacovigilance services as a one-stop regulatory and commercial gateway for foreign manufacturers entering Serbia.

The company maintains a portfolio of branded products including Buprefex (buprenorphine sublingual tablets in 2mg and 8mg), NORADRENALIN MEDIKUNION, Dobutamin Admeda and Dopamin Admeda (cardiovascular agents), Gastrogasac / Gastrogasac CONTROL (pantoprazole), and Silagra / Sildenafil PULMO (sildenafil products for erectile dysfunction and pulmonary hypertension). It operates its own warehouse facility under Good Distribution Practice (GDP) guidelines, ISO 9001:2015 certification, and regular Ministry of Health inspections. Distribution is conducted directly to 319+ state and private healthcare institutions across Serbia.

MEDIKUNION's business model combines pharmaceutical import margins, distribution transaction fees, and professional services fees for drug registration and marketing. The company maintains strategic relationships with the Ministry of Health, ALIMS (the Serbian medicines regulator), the Republic Health Insurance Fund, the Institute of Public Health, and international partners including the Stop TB Partnership Global Drug Facility, G.L. Pharma, and Admeda. The company is privately held with only 5 employees and has not disclosed funding rounds, revenue figures, or M&A activity.

Name

MEDIKUNION

Legal name

MEDIKUNION DOO BEOGRAD

Website

https://medikunion.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

1–10 employees

Short description

MEDIKUNION is a Belgrade-based pharmaceutical importer and distributor founded in 1994, specializing in unregistered medicines for over 319 Serbian healthcare institutions. It also distributes branded generics and provides drug registration and pharmacovigilance services.

Ownership category

akta.pro rank

Product category

Pharmaceutical Distribution & Import Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro industry

PRIMARYHLAIAJAF

Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor)

Healthcare & Life Sciences/Pharmaceuticals/Pharmaceutical Distribution & Wholesaling

SECONDARYHLAIAAAB

Specialty Care Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

• Pharmaceutical distribution
• Medicine importation
• Drug registration services
• Pharmacovigilance services
• Pharmaceutical marketing

Headquarters

HQ city

Belgrade

HQ country

Serbia

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Medicine Import: Import of unregistered medicines for the needs of patients and healthcare institutions in Serbia, operating within the framework of Serbian pharmaceutical regulations.
2. Pharmaceutical Distribution: Distribution of medicines and medical devices, operating under Good Distribution Practice (GDP) guidelines and ISO 9001:2015 standards. The company has its own warehouse space and operates in a system of regular inspections by the Ministry of Health of the Republic of Serbia.
3. Medicine Registration: Registration services for medicines in Serbia, facilitating market entry for pharmaceutical products.
4. Marketing: Marketing services for pharmaceutical products in the Serbian market.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels1 record

Core offering

MEDIKUNION imports, registers, distributes, and markets pharmaceutical products in Serbia, with a particular focus on unregistered medicines needed by patients and healthcare institutions. The company operates its own GDP-compliant warehouse and serves more than 319 state and private healthcare institutions with both branded pharmaceutical products (including Buprefex, Dobutamin Admeda, Dopamin Admeda, NORADRENALIN MEDIKUNION, Gastrogasac, and Silagra) and supporting services such as drug registration, pharmaceutical marketing, and pharmacovigilance.

Product overview

MEDIKUNION is a Serbian pharmaceutical company founded in 1994, 100% privately owned, specializing in the import, distribution, and registration of medicines in Serbia. The company offers a portfolio of registered pharmaceutical products including Buprefex® (buprenorphine sublingual tablets in 2mg and 8mg), Dobutamin Admeda 250 (inotropic agent), Dopamin Admeda 50 (vasopressor), NORADRENALIN MEDIKUNION (norepinephrine), Gastrogasac® and Gastrogasac® CONTROL (pantoprazole gastro-resistant tablets), and Silagra® and Sildenafil PULMO (sildenafil products for erectile dysfunction and pulmonary hypertension). The company's service offerings include drug registration, import of unregistered medicines, distribution with cold chain logistics capabilities, pharmaceutical marketing, and pharmacovigilance services. MEDIKUNION operates its own warehouse facilities and serves over 319 public and private healthcare institutions in Serbia.

Differentiator

Problem solved

Functional benefit

Products and services

• Buprefex® (buprenorphine) sublingual tablets

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and major.

• Ministry of Health of the Republic of Serbia (Ministarstvo zdravlja Republike Srbije)coreStrategic or Co-development PartnerThe company operates under the regulatory oversight of the Ministry of Health of the Republic of Serbia, which conducts regular inspections to ensure compliance with pharmaceutical distribution requirements.
• Agency for Medicines and Medical Devices of Serbia (ALIMS)coreStrategic or Co-development PartnerALIMS is the regulatory body responsible for medicines and medical devices in Serbia. MEDIKUNION works with ALIMS for medicine registration and pharmacovigilance activities.
• Republic Health Insurance Fund of SerbiamajorStrategic or Co-development PartnerCollaboration with the Republic Health Insurance Fund for healthcare coverage and reimbursement of pharmaceutical products distributed by MEDIKUNION.
• Institute of Public Health of Serbia 'Dr Milan Jovanović Batut'coreStrategic or Co-development PartnerPartnership with the national public health institute for disease control programs and health initiatives.
• Stop TB Partnership Global Drug FacilitycoreStrategic or Co-development PartnerPartnership for anti-tuberculosis medicines supply, providing access to TB medications for patients in Serbia through the Global Drug Facility program.
• G. L. PharmamajorTechnology or IntegrationManufacturer partner supplying Buprefex (buprenorphine) sublingual tablets distributed by MEDIKUNION in Serbia.
• AdmedamajorTechnology or IntegrationManufacturer partner supplying Dobutamin Admeda and Dopamin Admeda products for the Serbian market.
• Pharmaceutical Companies WorldwidemajorTechnology or IntegrationThe company establishes and maintains strong cooperation with pharmaceutical companies around the world with the goal of enabling fast access to high-quality medicines for Serbian patients.

Scale indicators3 records

Recent moves5 records

Expansion highlights3 records

Market position

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• LinkedInlinkedin.com/company/medikunion

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MEDIKUNION